NCT01282606View on ClinicalTrials.gov

Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

August 31, 2012

Conditions
Lumbar Vertebra Hernia
Interventions
DRUG

SI-6603

SI-6603 is administrated into the nucleus pulposus of an intervertebral disc.

Trial Locations (1)

92024

SKK, Encinitas

All Listed Sponsors
lead

Seikagaku Corporation

INDUSTRY

NCT01282606 - Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation | Biotech Hunter | Biotech Hunter